Miracle Mile Advisors LLC Trims Stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Miracle Mile Advisors LLC reduced its holdings in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 4.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 22,500 shares of the company’s stock after selling 1,000 shares during the quarter. Miracle Mile Advisors LLC’s holdings in BrightSpring Health Services were worth $383,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Intech Investment Management LLC bought a new stake in shares of BrightSpring Health Services during the 3rd quarter worth $159,000. Arizona State Retirement System bought a new position in BrightSpring Health Services in the second quarter valued at $163,000. nVerses Capital LLC raised its position in BrightSpring Health Services by 195.8% during the third quarter. nVerses Capital LLC now owns 14,200 shares of the company’s stock valued at $208,000 after purchasing an additional 9,400 shares in the last quarter. American Century Companies Inc. bought a new stake in BrightSpring Health Services during the second quarter worth about $216,000. Finally, BNP Paribas Financial Markets boosted its holdings in shares of BrightSpring Health Services by 5.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company’s stock worth $313,000 after purchasing an additional 1,011 shares in the last quarter.

BrightSpring Health Services Trading Up 2.7 %

NASDAQ BTSG opened at $18.48 on Friday. The stock has a market cap of $3.22 billion and a P/E ratio of -71.08. BrightSpring Health Services, Inc. has a fifty-two week low of $7.85 and a fifty-two week high of $20.25. The stock has a 50 day simple moving average of $18.21 and a two-hundred day simple moving average of $15.13. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). The business had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.72 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The firm’s revenue for the quarter was up 28.8% compared to the same quarter last year. On average, analysts forecast that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.

Analyst Upgrades and Downgrades

BTSG has been the subject of a number of recent research reports. Mizuho boosted their target price on BrightSpring Health Services from $17.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. BTIG Research lifted their price target on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Morgan Stanley upped their price objective on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. Bank of America lifted their target price on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Finally, KeyCorp assumed coverage on shares of BrightSpring Health Services in a research report on Friday, October 11th. They set a “sector weight” rating for the company. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $18.65.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.